Ribovate Therapeutics Ribovate is developing the next generation targeted mRNA-lipid nanoparticle therapeutic platform. Startup Details Co-Founded by: Drew Weissman and Hamideh Parhiz Participates in PCI Ventures UPstart Recent News All PCI Ventures Posts 2023 PCI Ventures at Pennovation Works Showcase Puts Startup Growth and the Entrepreneurial Journey in the Spotlight PCI highlights mRNA Innovation at JPM Penn Startups Raising Money in 2023 PCI Ventures Presents at Pennovation Works Showcase